Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT00132834
Eligibility Criteria:
Inclusion Criteria for All Participants:
* Physician-diagnosed asthma
* Symptoms consistent with persistent asthma in the year prior to study entry
* Able to speak and understand English
* Parent or guardian willing to provide informed consent
Exclusion Criteria for All Participants:
* Diagnoses indicating other lung-related disorders (e.g., cystic fibrosis, bronchopulmonary dysplasia \[BPD\])
* Allergy to latex
* Smoker
* Albuterol use within 12 hours of study entry
* Long-acting bronchodilator or leukotriene modifier use within 24 hours of study entry
* Unable to use the R-Tube. More information on this criterion can be found in the DAIT ICAC-EBC protocol.
Exclusion Criteria for Part A Participants:
* ICS or oral corticosteroid use in the month prior to study entry
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
17 Years
Study:
NCT00132834
Study Brief:
Protocol Section:
NCT00132834